Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The BARCODE 1 Study: The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.

NCT03857477 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT03857477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03857477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The BARCODE 1 Study: The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Observational
Overall status
Active, not recruiting
Start date
March 14, 2019
Completion date
December 31, 2028
Enrollment
4,700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer